2.2595
price up icon2.70%   0.0595
after-market アフターアワーズ: 2.26 0.0005 +0.02%
loading

Cytomed Therapeutics Ltd (GDTC) 最新ニュース

pulisher
Nov 20, 2024

CytoMed Therapeutics : Update on Clinical Milestone CytoMed Therapeutics Announces First Patient Dosed in its First in Human Phase I Clinical Trial of Allogeneic CAR Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematologica - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

CytoMed Therapeutics Limited Announces First Patient Dosed in Its First-In-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies - Marketscreener.com

Nov 20, 2024
pulisher
Oct 23, 2024

Discovering Penny Stocks On US Exchanges: 3 Picks Under $100M Market Cap - Simply Wall St

Oct 23, 2024
pulisher
Oct 17, 2024

Osteopore partners with NASDAQ-listed CytoMed to advance MSC-powered regeneration - Biotech Dispatch

Oct 17, 2024
pulisher
Oct 16, 2024

Osteopore Partners with CytoMed in Regenerative Medicine - TipRanks

Oct 16, 2024
pulisher
Oct 08, 2024

CytoMed begins clinical trial for innovative cancer therapy - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank - Marketscreener.com

Oct 07, 2024
pulisher
Oct 07, 2024

Cytomed Therapeutics announces NMRC co-funding support for ANGELICA trial - TipRanks

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed Launches Innovative CAR-T Cell Trial - TipRanks

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed begins clinical trial for innovative cancer therapy By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed Therapeutics’ first-in-human Phase I ANGELICA - GlobeNewswire

Oct 07, 2024
pulisher
Oct 07, 2024

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant - StockTitan

Oct 07, 2024
pulisher
Oct 04, 2024

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine - Yahoo Finance

Oct 04, 2024
pulisher
Oct 03, 2024

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed's strategy to cord blood-derived biologics through subsidiary, LongevityBank - The Manila Times

Oct 03, 2024
pulisher
Oct 03, 2024

CytoMed Therapeutics completes cash acquisition of Cord - GlobeNewswire

Oct 03, 2024
pulisher
Sep 30, 2024

GDTCCytoMed Therapeutics Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan

Sep 30, 2024
pulisher
Sep 30, 2024

CYTOMED THERAPEUTICS : AND SUBSIDIARIES UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Form 6 K - Marketscreener.com

Sep 30, 2024
pulisher
Sep 30, 2024

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 - GlobeNewswire

Sep 30, 2024
pulisher
Sep 30, 2024

CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates - Yahoo Finance

Sep 30, 2024
pulisher
Sep 25, 2024

Presenting on the Emerging Growth Conference 75 Day 2 on September 26 - GlobeNewswire

Sep 25, 2024
pulisher
Aug 25, 2024

CytoMed Therapeutics Limited acquired the licence and certain assets of Cellsafe International Sdn Bhd from Cellsafe Biotech Group for MYR 2.3 million. - Marketscreener.com

Aug 25, 2024
pulisher
Aug 20, 2024

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now - GlobeNewswire

Aug 20, 2024
pulisher
Jul 25, 2024

CytoMed Therapeutics (NASDAQ:GDTC) Trading Down 2% - Defense World

Jul 25, 2024
pulisher
Jul 17, 2024

CytoMed Therapeutics Ltd (GDTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Jul 17, 2024
pulisher
Jul 17, 2024

CytoMed Therapeutics Acquires Cord Blood Banking Licence - GlobeNewswire

Jul 17, 2024
pulisher
Jul 17, 2024

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers - GlobeNewswire

Jul 17, 2024
pulisher
Jul 17, 2024

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire Inc.

Jul 17, 2024
pulisher
Jun 27, 2024

CytoMed Therapeutics Limited Announces Board and Audit Committee Changes - Marketscreener.com

Jun 27, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off ... - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics to Ring Nasdaq Closing Bell - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics Limited Announces Closing of US$9,649,476 Firm Commitment Initial Public Offering - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo ... - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has ... - Quantisnow

Jun 20, 2024
pulisher
Jun 20, 2024

CytoMed Therapeutics : Board re organization Form 6 K - Marketscreener.com

Jun 20, 2024
pulisher
Jun 12, 2024

Natural Alternatives International (NASDAQ:NAII) Receives New Coverage from Analysts at StockNews.com - Defense World

Jun 12, 2024
pulisher
Jun 12, 2024

Viridian Therapeutics (NASDAQ:VRDN) Receives New Coverage from Analysts at Wolfe Research - Defense World

Jun 12, 2024
pulisher
Jun 11, 2024

Anti-aging Therapeutics Market Size, Scope, Growth and Forecast to 2031 - InsightAce Analytic

Jun 11, 2024
pulisher
Mar 20, 2024

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration - Yahoo Finance

Mar 20, 2024
pulisher
Mar 18, 2024

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies - Marketscreener.com

Mar 18, 2024
pulisher
Mar 04, 2024

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair - GlobeNewswire

Mar 04, 2024
pulisher
Feb 07, 2024

Healthcare Stocks Moving Wednesday: OGEN, FEMY, JSPR, ABEO, GDTC, CING, HUMA, NEXI - InvestorsObserver

Feb 07, 2024
pulisher
Jan 29, 2024

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology - Yahoo Finance

Jan 29, 2024
pulisher
Jan 23, 2024

GDTC Stock Price and Chart — NASDAQ:GDTC - TradingView

Jan 23, 2024
pulisher
Dec 05, 2023

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology - PR Newswire

Dec 05, 2023
pulisher
Nov 17, 2023

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update - PR Newswire

Nov 17, 2023
pulisher
Oct 24, 2023

Cytomed Therapeutics Limited (GDTC-Q) QuotePress Release - The Globe and Mail

Oct 24, 2023
pulisher
Sep 25, 2023

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology - PR Newswire

Sep 25, 2023
pulisher
Aug 16, 2023

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency - 팜뉴스

Aug 16, 2023
pulisher
Jul 25, 2023

Novel T-Cell Immunotherapies Market Share, Size, Growth and Forecast to 2031 - InsightAce Analytic

Jul 25, 2023
pulisher
Jul 11, 2023

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today? - InvestorPlace

Jul 11, 2023
pulisher
Jul 06, 2023

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US - PR Newswire

Jul 06, 2023
pulisher
Jun 07, 2023

CARISMA Therapeutics Stock (NASDAQ:CARM), Quotes and News Summary - Benzinga

Jun 07, 2023
pulisher
May 10, 2023

CytoMed and MD Anderson partner to use gdTc for cancer treatment - Pharmaceutical Technology

May 10, 2023
pulisher
May 09, 2023

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology - PR Newswire

May 09, 2023
pulisher
Apr 17, 2023

Peter Choo-backed biomed firm CytoMed lists on Nasdaq - The Edge Singapore

Apr 17, 2023
pulisher
Apr 14, 2023

GDTC IPO NewsSingapore-based cancer biotech CytoMed Therapeutics prices US IPO at $4 low end - Renaissance Capital

Apr 14, 2023
pulisher
Apr 13, 2023

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering - PR Newswire

Apr 13, 2023
pulisher
Mar 08, 2023

CARISMA Therapeutics (NASDAQ:CARM) Stock Quotes, Forecast and News Summary - Benzinga

Mar 08, 2023
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):